Author

Tom Holvoet 1

1 UZ Ghent,Gastro-enterology,Gent,Belgium

EARLY FIBROSTENOSIS IN CROHN’S DISEASE IS ASSOCIATED WITH MULTIPLE SUSCEPTIBILITY LOCI ON IMMUNOCHIP ANALYSIS

Tom Holvoet, Peter Bossuyt, Isabelle Cleynen, Isabelle De Kock, Pieter Hindryckx, Severine Vermeire, Debby Laukens, Martine De Vos

LOCAL ROCK INHIBITION ATTENUATES DEVELOPMENT OF INTESTINAL FIBROSIS IN MURINE COLITIS

Tom Holvoet, Sarah Devriese, Karolien Castermans, Sandro Boland, Pieter Hindryckx, Lindsey Devisscher, Arnaud Bourin, Olivier Defert, Debby Laukens

LOCAL ROCK INHIBITION ATTENUATES DEVELOPMENT OF INTESTINAL FIBROSIS IN MURINE COLITIS

Tom Holvoet

OPEN LABEL OBSERVATIONAL STUDY EVALUATING THE EFFECT OF INDUCTION THERAPY WITH VEDOLIZUMAB IN PATIENTS WITH MODERATE TO SEVERE INFLAMMATORY BOWEL DISEASE INTOLERANT/RESISTANT TO AT LEAST TWO BIOLOGICALS

Martine De Vos, Barbara Dhooghe, Severine Vermeire, Edouard Louis, Mana Fazia, An Elewaut, Peter Bossuyt, Filip Baert, Catherine Reenaers, Marc Van Gossum, Elisabeth Macken, Marc Ferrante, Pieter Hindryckx, Sophie De Wit, Tom Holvoet, Denis Franchimont

SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY

Cara De Galan, Harald Peeters, Francisco Mesonero Gismero, Marie Truyens, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocío Ferreiro-Iglesias, Yamile Zabana, Tom Holvoet, Laia Peries Reverter, Jeroen Geldof, Triana Lobaton, Martine De Vos

Item 1 - 5 / 5
1